Genetic Evidence of the Causal Relationship Between Chronic Liver Diseases and Musculoskeletal Disorders

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2024 Feb 6

PMID 38321551

Authors

Zhengjie Lu

Xuefei Li

Yongjian Qi

Bin Li

Liaobin Chen

Affiliations

Soon will be listed here.

Abstract

Background: Chronic liver diseases constitute a major global public health burden, posing a substantial threat to patients' daily lives and even survival due to the potential development of musculoskeletal disorders. Although the relationship between chronic liver diseases and musculoskeletal disorders has received extensive attention, their causal relationship has not been comprehensively and systematically investigated.

Methods: This study aimed to assess the causal relationships between viral hepatitis, primary biliary cholangitis, primary sclerosing cholangitis (PSC), liver cirrhosis, and hepatocellular carcinoma (HCC) with osteoporosis, osteoarthritis, and sarcopenia through bidirectional Mendelian randomization (MR) research. The traits related to osteoporosis and osteoarthritis included both overall and site-specific phenotypes, and the traits linked to sarcopenia involved indicators of muscle mass and function. Random-effect inverse-variance weighted (IVW), weighted median, MR-Egger, and Causal Analysis Using the Summary Effect Estimates were used to evaluate causal effects, with IVW being the main analysis method. To enhance robustness, sensitivity analyses were performed using Cochran's Q test, MR-Egger intercept, MR-PRESSO global test, funnel plots, leave-one-out analyses, and latent causal variable model.

Results: The forward MR analysis indicated that PSC can reduce forearm bone mineral density (beta = - 0.0454, 95% CI - 0.0798 to - 0.0110; P = 0.0098) and increase the risk of overall osteoarthritis (OR = 1.012, 95% CI 1.002-1.022; P = 0.0247), while HCC can decrease grip strength (beta = - 0.0053, 95% CI - 0.008 to - 0.0025; P = 0.0002). The reverse MR analysis did not find significant causal effects of musculoskeletal disorders on chronic liver diseases. Additionally, no heterogeneity or pleiotropy was detected.

Conclusions: These findings corroborate the causal effects of PSC on osteoporosis and osteoarthritis, as well as the causal impact of HCC on sarcopenia. Thus, the implementation of comprehensive preventive measures is imperative for PSC and HCC patients to mitigate the risk of musculoskeletal disorders, ultimately improving their quality of life.

References

Chen J, Yuan S, Fu T, Ruan X, Qiao J, Wang X . Gastrointestinal Consequences of Type 2 Diabetes Mellitus and Impaired Glycemic Homeostasis: A Mendelian Randomization Study. Diabetes Care. 2023; 46(4):828-835. PMC: 10091506. DOI: 10.2337/dc22-1385. View

Hartwig F, Davey Smith G, Bowden J . Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017; 46(6):1985-1998. PMC: 5837715. DOI: 10.1093/ije/dyx102. View

Chen Y, Fang W, Wang C, Kao T, Chang Y, Yang H . Crosssectional Assessment of Bone Mass Density in Adults with Hepatitis B Virus and Hepatitis C Virus Infection. Sci Rep. 2019; 9(1):5069. PMC: 6433944. DOI: 10.1038/s41598-019-41674-4. View

Jones G, Trajanoska K, Santanasto A, Stringa N, Kuo C, Atkins J . Genome-wide meta-analysis of muscle weakness identifies 15 susceptibility loci in older men and women. Nat Commun. 2021; 12(1):654. PMC: 7844411. DOI: 10.1038/s41467-021-20918-w. View

Wang L, Chen L, Chen K . Hormone-Related and Drug-Induced Osteoporosis: A Cellular and Molecular Overview. Int J Mol Sci. 2023; 24(6). PMC: 10054048. DOI: 10.3390/ijms24065814. View

Zhao Z, Zou J, Huang X, Fan Y, Wang K . Assessing causal relationships between sarcopenia and nonalcoholic fatty liver disease: A bidirectional Mendelian randomization study. Front Nutr. 2022; 9:971913. PMC: 9682105. DOI: 10.3389/fnut.2022.971913. View

Bering T, Diniz K, Coelho M, Vieira D, Soares M, Kakehasi A . Association between pre-sarcopenia, sarcopenia, and bone mineral density in patients with chronic hepatitis C. J Cachexia Sarcopenia Muscle. 2018; 9(2):255-268. PMC: 5879980. DOI: 10.1002/jcsm.12269. View

Lu K, Shi T, Shen S, Shi Y, Gao H, Wu J . Defects in a liver-bone axis contribute to hepatic osteodystrophy disease progression. Cell Metab. 2022; 34(3):441-457.e7. DOI: 10.1016/j.cmet.2022.02.006. View

Muratori L, Lohse A, Lenzi M . Diagnosis and management of autoimmune hepatitis. BMJ. 2023; 380:e070201. DOI: 10.1136/bmj-2022-070201. View

10.

Burgess S, Butterworth A, Thompson S . Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013; 37(7):658-65. PMC: 4377079. DOI: 10.1002/gepi.21758. View

11.

Zheng H, Forgetta V, Hsu Y, Estrada K, Rosello-Diez A, Leo P . Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture. Nature. 2015; 526(7571):112-7. PMC: 4755714. DOI: 10.1038/nature14878. View

12.

Bowden J, Davey Smith G, Haycock P, Burgess S . Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016; 40(4):304-14. PMC: 4849733. DOI: 10.1002/gepi.21965. View

13.

Pei Y, Liu Y, Yang X, Zhang H, Feng G, Wei X . The genetic architecture of appendicular lean mass characterized by association analysis in the UK Biobank study. Commun Biol. 2020; 3(1):608. PMC: 7585446. DOI: 10.1038/s42003-020-01334-0. View

14.

Chen X, Kong J, Pan J, Huang K, Zhou W, Diao X . Kidney damage causally affects the brain cortical structure: A Mendelian randomization study. EBioMedicine. 2021; 72:103592. PMC: 8498227. DOI: 10.1016/j.ebiom.2021.103592. View

15.

Barchetta I, Lubrano C, Cimini F, Dule S, Passarella G, Dellanno A . Liver fibrosis is associated with impaired bone mineralization and microstructure in obese individuals with non-alcoholic fatty liver disease. Hepatol Int. 2022; 17(2):357-366. DOI: 10.1007/s12072-022-10461-1. View

16.

Lee J, Jukarainen S, Karvanen A, Dixon P, Davies N, Davey Smith G . Quantifying the causal impact of biological risk factors on healthcare costs. Nat Commun. 2023; 14(1):5672. PMC: 10499912. DOI: 10.1038/s41467-023-41394-4. View

17.

Cui A, Xiao P, Fan Z, Lei J, Han S, Zhang D . Causal association of NAFLD with osteoporosis, fracture and falling risk: a bidirectional Mendelian randomization study. Front Endocrinol (Lausanne). 2023; 14:1215790. PMC: 10446969. DOI: 10.3389/fendo.2023.1215790. View

18.

Minton K . The FinnGen study: disease insights from a 'bottlenecked' population. Nat Rev Genet. 2023; 24(4):207. DOI: 10.1038/s41576-023-00584-y. View

19.

Saeki C, Takano K, Oikawa T, Aoki Y, Kanai T, Takakura K . Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis. BMC Musculoskelet Disord. 2019; 20(1):615. PMC: 6933666. DOI: 10.1186/s12891-019-2983-4. View

20.

Saponaro F, Saba A, Zucchi R . An Update on Vitamin D Metabolism. Int J Mol Sci. 2020; 21(18). PMC: 7554947. DOI: 10.3390/ijms21186573. View